Marc Wilson
CIK 1702265 · CFO · last filed 2024-09-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.69M
Companies
2
Total Filings
17
Lifetime Open-Market Net
-$6.64M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRNX | CFO | 136,092 | $34.47 | $4.69M | -$6.64M | 15 | 2024-09-30 |
| Cidara Therapeutics, Inc. (CDTX) Delisted | Chief Accounting Officer | 10,356 | $221.38 | $2.29M | $0 | 2 | 2017-09-19 |
Recent Filings · Page 2 of 2
17 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-03-03 | CRNX | Grant (A) | +24,200 | $0 | EDGAR |
| 2022-03-02 | CRNX | Grant (A) | +19,500 | $0 | EDGAR |
| 2021-03-02 | CRNX | Grant (A) | — | $0 | EDGAR |
| 2020-02-26 | CRNX | Grant (A) | — | $0 | EDGAR |
| 2019-03-12 | CRNX | Grant (A) | — | $0 | EDGAR |
| 2017-09-19 | Cidara Therapeutics, Inc. (CDTX) Delisted | Mixed | +5,000 | $0 | EDGAR |
| 2017-04-04 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–17 of 17
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.